Steven M. Paul

6.0k total citations · 2 hit papers
64 papers, 4.9k citations indexed

About

Steven M. Paul is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Steven M. Paul has authored 64 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 9 papers in Surgery. Recurrent topics in Steven M. Paul's work include Receptor Mechanisms and Signaling (10 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Neuroscience and Neuropharmacology Research (7 papers). Steven M. Paul is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Neuroscience and Neuropharmacology Research (7 papers). Steven M. Paul collaborates with scholars based in United States, Czechia and Germany. Steven M. Paul's co-authors include Perry H. Moore, R. H. Purdy, A. Leslie Morrow, Patricia Painter, Jacqueline N. Crawley, Susan Carey, Laurie Carlson, Jeffrey Myll, Nancy L. Ascher and Maria Dorota Majewska and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Steven M. Paul

63 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain.

1991 829 citations Steven M. Paul et al. profile →
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial

2023 104 citations Inder Kaul, Sharon Sawchak et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven M. Paul United States	36	1.4k	943	767	762	567	64	4.9k
Birgit Stoffel‐Wagner Germany	49	539 0.4×	534 0.6×	1.0k 1.3×	1.0k 1.4×	812 1.4×	200	7.2k
Kiyoshi Matsumura Japan	52	1.4k 1.0×	430 0.5×	421 0.5×	1.6k 2.1×	2.0k 3.6×	220	8.4k
Tammy Scott United States	44	478 0.3×	636 0.7×	213 0.3×	601 0.8×	1.2k 2.1×	123	7.2k
Susan E. Shoaf United States	31	638 0.5×	273 0.3×	336 0.4×	777 1.0×	799 1.4×	81	3.8k
Robert L. Brunner United States	35	575 0.4×	438 0.5×	222 0.3×	466 0.6×	1.4k 2.4×	113	6.2k
Randall M. Zusman United States	33	239 0.2×	297 0.3×	275 0.4×	740 1.0×	400 0.7×	88	5.1k
Frans H. H. Leenen Canada	53	656 0.5×	460 0.5×	568 0.7×	2.3k 3.0×	1.1k 1.9×	298	8.9k
David E. Bush United States	41	984 0.7×	750 0.8×	787 1.0×	458 0.6×	279 0.5×	79	8.2k
Hiroaki Araki Japan	31	1.6k 1.2×	206 0.2×	149 0.2×	1.4k 1.9×	542 1.0×	267	4.2k
Ranga Krishnan United States	46	325 0.2×	934 1.0×	437 0.6×	454 0.6×	570 1.0×	117	7.6k

Countries citing papers authored by Steven M. Paul

Since Specialization

Citations

This map shows the geographic impact of Steven M. Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Paul more than expected).

Fields of papers citing papers by Steven M. Paul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Paul. The network helps show where Steven M. Paul may publish in the future.

Co-authorship network of co-authors of Steven M. Paul

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Paul. A scholar is included among the top collaborators of Steven M. Paul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Paul. Steven M. Paul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harris, Carolyn, Marilyn J. Hammer, Yvette P. Conley, et al.. (2025). Impact of Multimorbidity on Symptom Burden and Symptom Clusters in Patients Receiving Chemotherapy. Cancer Medicine. 14(3). e70418–e70418. 1 indexed citations

Potter, William Z., Neil Buckholtz, & Steven M. Paul. (2024). The origins of ADNI. Alzheimer s & Dementia. 20(11). 8188–8191. 4 indexed citations

Cooley, Mary E., et al.. (2024). Lower Income, Smoking, Cardiopulmonary Comorbidities, and Higher Symptom Burden Influence the Occurrence of Cough in Patients Receiving Chemotherapy. Oncology nursing forum. 51(4). E4–E24. 1 indexed citations

Correll, Christoph U., Andrew C. Miller, Sharon Sawchak, et al.. (2023). Safety and efficacy of KarXT (Xanomeline Trospium) in Schizophrenia in the Phase 3, Randomized, Double-Blind, Placebo-Controlled EMERGENT-2 Trial. CNS Spectrums. 28(2). 220–220. 8 indexed citations

Kaul, Inder, Sharon Sawchak, Christoph U. Correll, et al.. (2023). Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial. The Lancet. 403(10422). 160–170. 104 indexed citations breakdown →

Singh, Komal, Keenan A. Pituch, Qiyun Zhu, et al.. (2022). Distinct Nausea Profiles Are Associated With Gastrointestinal Symptoms in Oncology Patients Receiving Chemotherapy. Cancer Nursing. 46(2). 92–102. 5 indexed citations

Dracup, Kathleen, Sharon McKinley, Bárbara Riegel, et al.. (2009). A Randomized Clinical Trial to Reduce Patient Prehospital Delay to Treatment in Acute Coronary Syndrome. Circulation Cardiovascular Quality and Outcomes. 2(6). 524–532. 119 indexed citations

Engler, Mary B., Mary B. Engler, Marguerite M. Engler, et al.. (2004). Flavonoid-Rich Dark Chocolate Improves Endothelial Function and Increases Plasma Epicatechin Concentrations in Healthy Adults. Journal of the American College of Nutrition. 23(3). 197–204. 357 indexed citations

Dibble, Suzanne L., Stephanie Roberts, Patricia A. Robertson, & Steven M. Paul. (2002). Risk Factors for Ovarian Cancer: Lesbian and Heterosexual Women. Oncology nursing forum. 29(1). E1–E7. 58 indexed citations

10.

Painter, Patricia, Laurie Carlson, Susan Carey, Steven M. Paul, & Jeffrey Myll. (2000). Low-functioning hemodialysis patients improve with exercise training. American Journal of Kidney Diseases. 36(3). 600–608. 128 indexed citations

11.

Glinn, Michele, Binhui Ni, & Steven M. Paul. (1995). Characterization of Na⁺‐Dependent Phosphate Uptake in Cultured Fetal Rat Cortical Neurons. Journal of Neurochemistry. 65(5). 2358–2365. 19 indexed citations

12.

Hlatky, Mark A., et al.. (1994). Functional capacity after cardiac surgery in elderly patients. Journal of the American College of Cardiology. 24(1). 104–108. 48 indexed citations

13.

Korenbrot, Carol C., Dyanne D. Affonso, Linda J. Mayberry, & Steven M. Paul. (1994). Associations of the Use of Prenatal Care with Low Birthweight in Asian Pacific Women in Hawaii.. PubMed. 2(3). 181–194. 1 indexed citations

14.

Rapaport, Mark Hyman, Cathy G. McAllister, Jin‐Hee Han, et al.. (1994). Increased serum soluble interleukin-2 receptors in caucasian and Korean schizophrenic patients. Biological Psychiatry. 35(10). 767–771. 50 indexed citations

15.

Ator, Nancy A., Kathleen A. Grant, Robert H. Purdy, Steven M. Paul, & R R Griffiths. (1993). Drug discrimination analysis of endogenous neuroactive steroids in rats. European Journal of Pharmacology. 241(2-3). 237–243. 104 indexed citations

16.

Angel, Itzchak, et al.. (1992). Regulation of the anorectic drug recognition site during glucoprivic feeding. Brain Research Bulletin. 28(2). 201–207. 4 indexed citations

17.

Jennings, Bonnie Mowinski, et al.. (1989). Contextual Regression Analysis. Nursing Research. 38(2). 124–124. 5 indexed citations

18.

Labarca, Rodrigo, John W. Thomas, Markku Koulu, et al.. (1988). A central 6-hydroxydopamine lesion prevents fluphenazine-induced increase in plasma homovanillic acid. Brain Research Bulletin. 20(5). 567–571. 10 indexed citations

19.

Angel, Itzchak, et al.. (1987). Characterization of [³H]Mazindol Binding in Rat Brain: Sodium‐Sensitive Binding Correlates with the Anorectic Potencies of Phenylethylamines. Journal of Neurochemistry. 48(2). 491–497. 15 indexed citations

20.

Amsterdam, Jay D., Werner Henle, Andrew Winokur, et al.. (1986). Serum antibodies to Epstein-Barr virus in patients with major depressive disorder. American Journal of Psychiatry. 143(12). 1593–1596. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact